Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
BioGene Therapeutics Inc. See All Filings	D	2026-08-07 10:51:06 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0002140719 Filed Document 0002140719-26-000005 Exclusions or Exemptions 506b Accepted Date 2026-08-07 10:51:06 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
BioGene Therapeutics Inc. See All Filings	D	2026-08-06 15:16:17 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0002140719 Filed Document 0002140719-26-000004 Exclusions or Exemptions 506b Accepted Date 2026-08-06 15:16:17 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
BioGene Therapeutics Inc. See All Filings	D	2026-08-06 14:19:20 UTC
Amount To Be Raised $250,000 Associated Brokers / Dealers N/A CIK Number 0002140719 Filed Document 0002140719-26-000003 Exclusions or Exemptions 506b Accepted Date 2026-08-06 14:19:20 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
BioGene Therapeutics Inc. See All Filings	D	2026-08-06 13:45:27 UTC
Amount To Be Raised $250,000 Associated Brokers / Dealers N/A CIK Number 0002140719 Filed Document 0002140719-26-000002 Exclusions or Exemptions 506b Accepted Date 2026-08-06 13:45:27 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
BioGene Therapeutics Inc. See All Filings	D	2026-07-23 14:11:40 UTC
Amount To Be Raised $4,550,000 Associated Brokers / Dealers N/A CIK Number 0002140719 Filed Document 0002140719-26-000001 Exclusions or Exemptions 506b Accepted Date 2026-07-23 14:11:40 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Option To Acquire